MoneyWorks4Me

Piramal Pharma informs about disclosure

10 Sep 2024 Evaluate
Piramal Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund I & East Bridge Capital Master Fund.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..